PHI with Acute yellow liver atrophy
How does this condition affect your private health insurance?
Acute yellow liver atrophy, now largely termed acute liver failure, is a rare but life-threatening condition characterized by the rapid development of severe liver dysfunction, typically within weeks of initial liver injury, in an individual with no pre-existing liver disease. It manifests with jaundice, coagulopathy, and hepatic encephalopathy. Common causes include viral hepatitis (e.g., A, B, E), drug-induced liver injury (e.g., acetaminophen overdose), autoimmune hepatitis, and some metabolic disorders. The rapid progression often leads to multi-organ failure, cerebral edema, and a high mortality rate without prompt diagnosis and aggressive medical management, often culminating in liver transplantation.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to a few weeks, typically less than 26 weeks from symptom onset to encephalopathy.
Duration of Illness (Lifetime)
A one-time acute event; survival leads to recovery or a chronic state post-transplant; often fatal without intervention.
Cost of Treatment (Initial)
Very high, ranging from tens of thousands to hundreds of thousands of dollars, particularly if intensive care and diagnostics are required.
Cost of Treatment (Lifetime)
Potentially millions of dollars if liver transplantation is performed, including surgery, hospitalization, and lifelong immunosuppression. If fatal, the cost is limited to the acute care phase.
Mortality Rate
High, ranging from 40% to 80% without liver transplantation, depending on etiology and severity. Even with transplant, mortality can be significant.
Risk of Secondary Damages
Very high (>80%), including acute kidney injury, cerebral edema, sepsis, gastrointestinal bleeding, and multi-organ failure. Neurological sequelae are common even in survivors.
Probability of Full Recovery
Variable, approximately 20-30% in severe cases without transplantation, depending heavily on the cause (e.g., better for acetaminophen overdose if treated early). With successful transplantation, functional recovery is high, but with lifelong medication.
Underlying Disease Risk
High, as the condition is often triggered by specific causes such as viral hepatitis (e.g., Hepatitis B, A, E), drug-induced liver injury (e.g., acetaminophen toxicity), autoimmune hepatitis, or certain metabolic disorders (e.g., Wilson's disease). These are often the cause rather than co-morbidities.